Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Koyama, Takafumi"" wg kryterium: Autor


Tytuł:
A Screening Method Using Anomaly Detection on a Smartphone for Patients With Carpal Tunnel Syndrome: Diagnostic Case-Control Study
Autorzy:
Koyama, Takafumi
Sato, Shusuke
Toriumi, Madoka
Watanabe, Takuro
Nimura, Akimoto
Okawa, Atsushi
Sugiura, Yuta
Fujita, Koji
Pokaż więcej
Temat:
Information technology
T58.5-58.64
Public aspects of medicine
RA1-1270
Źródło:
JMIR mHealth and uHealth, Vol 9, Iss 3, p e26320 (2021)
Opis pliku:
electronic resource
Relacje:
https://mhealth.jmir.org/2021/3/e26320; https://doaj.org/toc/2291-5222
Dostęp URL:
https://doaj.org/article/e15e1650558d4431919e7e05804baab4  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma
Autorzy:
Shirai, YukinaAff1, Aff2
Ueno, Toshihide
Kojima, Shinya
Ikeuchi, HiroshiAff1, Aff3
Kitada, Rina
Koyama, Takafumi
Takahashi, Fumiyuki
Takahashi, Kazuhisa
Ichimura, Koichi
Yoshida, Akihiko
Sugino, Hirokazu
Mano, Hiroyuki
Narita, Yoshitaka
Takahashi, MasamichiAff7, IDs1106002404563z_cor14
Kohsaka, ShinjiAff1, IDs1106002404563z_cor15
Pokaż więcej
Źródło:
Journal of Neuro-Oncology. :1-14
Czasopismo naukowe
Tytuł:
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition
Autorzy:
Mishima, Saori
Naito, Yoichi
Akagi, Kiwamu
Hayashi, Naomi
Hirasawa, Akira
Hishiki, Tomoro
Igarashi, Ataru
Ikeda, Masafumi
Kadowaki, Shigenori
Kajiyama, Hiroaki
Kato, Motohiro
Kenmotsu, Hirotsugu
Kodera, Yasuhiro
Komine, Keigo
Koyama, Takafumi
Maeda, Osamu
Miyachi, Mitsuru
Nishihara, Hiroshi
Nishiyama, Hiroyuki
Ohga, Shouichi
Okamoto, Wataru
Oki, Eiji
Ono, Shigeru
Sanada, Masashi
Sekine, Ikuo
Takano, Tadao
Tao, Kayoko
Terashima, Keita
Tsuchihara, Katsuya
Yatabe, Yasushi
Yoshino, Takayuki
Baba, EishiAff17, IDs10147023023979_cor32
Pokaż więcej
Źródło:
International Journal of Clinical Oncology. 28(10):1237-1258
Czasopismo naukowe
Tytuł:
Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022
Autorzy:
Ando, YuichiAff1, IDs10147023023822_cor1
Nishiyama, Hiroyuki
Shimodaira, Hideki
Takano, Nao
Sakaida, Emiko
Matsumoto, Koji
Nakanishi, Koki
Sakai, Hideki
Tsukamoto, Shokichi
Komine, Keigo
Yasuda, Yoshinari
Kato, Taigo
Fujiwara, Yutaka
Koyama, Takafumi
Kitamura, Hiroshi
Kuwabara, Takashige
Yonezawa, Atsushi
Okumura, Yuta
Yakushijin, Kimikazu
Nozawa, KazukiAff18, Aff19
Goto, Hideaki
Matsubara, Takeshi
Hoshino, Junichi
Yanagita, MotokoAff21, Aff23
Pokaż więcej
Źródło:
International Journal of Clinical Oncology. 28(10):1315-1332
Czasopismo naukowe
Tytuł:
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumors
Autorzy:
Mishima, Saori
Naito, Yoichi
Akagi, Kiwamu
Hayashi, Naomi
Hirasawa, Akira
Hishiki, Tomoro
Igarashi, Ataru
Ikeda, Masafumi
Kadowaki, Shigenori
Kajiyama, Hiroaki
Kato, Motohiro
Kenmotsu, Hirotsugu
Kodera, Yasuhiro
Komine, Keigo
Koyama, Takafumi
Maeda, Osamu
Miyachi, Mitsuru
Nishihara, Hiroshi
Nishiyama, Hiroyuki
Ohga, Shouichi
Okamoto, Wataru
Oki, Eiji
Ono, Shigeru
Sanada, Masashi
Sekine, Ikuo
Takano, Tadao
Tao, Kayoko
Terashima, Keita
Tsuchihara, Katsuya
Yatabe, Yasushi
Yoshino, Takayuki
Baba, EishiAff17, IDs10147023023608_cor32
Pokaż więcej
Źródło:
International Journal of Clinical Oncology. 28(8):941-955
Czasopismo naukowe
Tytuł:
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors
Autorzy:
Naito, Yoichi
Mishima, Saori
Akagi, Kiwamu
Hayashi, Naomi
Hirasawa, Akira
Hishiki, Tomoro
Igarashi, Ataru
Ikeda, Masafumi
Kadowaki, Shigenori
Kajiyama, Hiroaki
Kato, Motohiro
Kenmotsu, Hirotsugu
Kodera, Yasuhiro
Komine, Keigo
Koyama, Takafumi
Maeda, Osamu
Miyachi, Mitsuru
Nishihara, Hiroshi
Nishiyama, Hiroyuki
Ohga, Shouichi
Okamoto, Wataru
Oki, Eiji
Ono, Shigeru
Sanada, Masashi
Sekine, Ikuo
Takano, Tadao
Tao, Kayoko
Terashima, Keita
Tsuchihara, Katsuya
Yatabe, Yasushi
Yoshino, Takayuki
Baba, EishiAff22, IDs10147023023457_cor32
Pokaż więcej
Źródło:
International Journal of Clinical Oncology. 28(7):827-840
Czasopismo naukowe
Tytuł:
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
Autorzy:
Carranza, Omar
Greco, Martin Alberto
Coward, Jim
Joshua, Anthony
Karapetis, Christos
Hart, Christopher
Zhang, Alison
Prenen, Hans
Goeminne, Jean-Charles
Machiels, Jean-Pascal
Rottey, Sylvie
Corassa, Marcelo
Molin, Graziela Zibetti Dal
Tiscoski, Katsuki
Jardim, Denis Leonardo Fontes
Mak, Milena
Fu, Wei
Yao, Herui
Huang, Jing
Jiang, Haiping
Qin, Shukui
Chen, Baoshi
Yan, Dong
Yang, Yu
Loriot, Yohann
Le Tourneau, Christophe
Penel, Nicolas
Salas, Sébastien
Blay, Jean-Yves
Brachet, Pierre-Emmanuel
Durando, Xavier
Emambux, Sheik
Ravaud, Alain
Folprecht, Gunnar
Arnold, Dirk
Schuler, Martin
Ahrens, Marit
Golf, Alexander
Haag, Georg Martin
Lordick, Florian
Desuki, Alexander
Cazzaniga, Marina
Ciardiello, Fortunato
Milella, Michele
Koyama, Takafumi
Hirooka, Yoshiki
Okamoto, Wataru
Aogi, Kenjiro
Kuboki, Yasutoshi
Lee, Jungyun
Kim, Sung-Bae
Ahn, Myung-Ju
Chang, Jong Hee
Kim, Yong-Man
Nam, Do-Hyun
Park, Jae-Sung
Lugowska, Iwona
Paz-Ares, Luis
Moreno, Victor
Cervantes, Andres
Calvo, Mariona
Falcon, Alejandro
Gonzalez, Antonio
Tabernero, Josep
Martinez Bueno, Alejandro
García-Corbacho, Javier
Longo, Federico
Yen, Chia-Jui
Chen, Jen-Shi
Hou, Ming-Feng
Chao, Yee
Rau, Kun-Ming
Chiu, Tai-Jan
Feng, Yin-Hsun
Hsu, Chih-Hung
Huang, Wen-Tsung
Lai, Kuan-Ming
Yeh, Su-peng
Palmer, Daniel
Minchom, Anna
Winter, Helen
Welsh, Liam
Plummer, Ruth
Iyer, Gopakumar
Gutierrez, Martin
Bilen, Mehmet
Arrowsmith, Edward
Pant, Shubham
Spigel, David Robert
Zandberg, Dan Paul
Doroshow, Deborah
Lu-Emerson, Christine
Moezi, Mehdi
Paulson, Scott
Reardon, David
Ward, Patrick
Chaves, Jorge
Grigg, Claud
Hussein, Atif
Manda, Sudhir
Monticelli, Michael
Qamar, Rubina
Richey, Stephen L
Tamura, David
Wilks, Sharon
Iyer, Gopa
Witt, Olaf
Doi, Toshihiko
Reardon, David A
Massard, Christophe
Stuyckens, Kim
Crow, Lauren
Najmi, Saltanat
Hammond, Constance
Thomas, Shibu
Santiago-Walker, Ademi
Triantos, Spyros
Sweiti, Hussein
Pokaż więcej
Źródło:
In The Lancet Oncology August 2023 24(8):925-935
Czasopismo naukowe
Tytuł:
Phase I study of the VEGF/Ang-2 inhibitor BI 836880 alone or combined with the anti-programmed cell death protein-1 antibody ezabenlimab in Japanese patients with advanced solid tumors
Autorzy:
Yamamoto, Noboru
Koyama, Takafumi
Shimizu, ToshioAff1, Aff7
Todaka, Akiko
Kawakami, Takeshi
Erzen, Damijan
Sarashina, Akiko
Li, Bin
Hou, Jianrui
Yamazaki, KentaroAff2, IDs00280023045276_cor10
Pokaż więcej
Źródło:
Cancer Chemotherapy and Pharmacology. 91(6):469-480
Czasopismo naukowe
Tytuł:
Ocular toxicity of investigational anti-cancer drugs in early phase clinical trials
Autorzy:
Takamizawa, Shigemasa
Katsuya, YukiAff1, IDs10637022013218_cor2
Chen, Yi-Ning
Mizuno, Takaaki
Koyama, Takafumi
Sudo, Kazuki
Yoshida, Tatsuya
Kondo, Shunsuke
Iwasa, Satoru
Yonemori, Kan
Shimizu, Toshio
Yamamoto, Noboru
Suzuki, Shigenobu
Pokaż więcej
Źródło:
Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 41(1):173-181
Czasopismo naukowe
Tytuł:
Oral formulation of bendamustine hydrochloride for patients with advanced solid tumors; a phase 1 study
Autorzy:
Shimizu, ToshioAff1, Aff2, IDs10637022013076_cor1
Nakagawa, Kazuhiko
Hayashi, Hidetoshi
Iwasa, Tsutomu
Kawakami, Hisato
Watanabe, Satomi
Yamamoto, Noboru
Yonemori, Kan
Koyama, Takafumi
Sato, Jun
Tamura, KenjiAff1, Aff4
Kikuchi, Keiichi
Akaike, Kenichiro
Takeda, Shiho
Takeda, MasayukiAff3, Aff6
Pokaż więcej
Źródło:
Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 41(1):1-12
Czasopismo naukowe
Tytuł:
A feasibility study of lenvatinib plus pembrolizumab in Japanese patients with advanced solid tumors
Autorzy:
Kitano, ShigehisaAff1, Aff2, IDs0028002204480w_cor1
Fujiwara, YutakaAff1, Aff3
Shimizu, Toshio
Iwasa, Satoru
Yonemori, Kan
Kondo, Shunsuke
Shimomura, AkihikoAff1, Aff4
Koyama, Takafumi
Ebata, Takahiro
Ikezawa, Hiroki
Hayata, Nozomi
Minoshima, Yukinori
Miura, Takuma
Kubota, Tomoki
Yamamoto, Noboru
Pokaż więcej
Źródło:
Cancer Chemotherapy and Pharmacology. 90(6):523-529
Czasopismo naukowe
Tytuł:
Phase I study of envafolimab (KN035), a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumors
Autorzy:
Shimizu, ToshioAff1, Aff3, IDs10637022012877_cor1
Nakajima, Takako EguchiAff2, Aff4
Yamamoto, Noboru
Yonemori, Kan
Koyama, Takafumi
Kondo, Shunsuke
Sunakawa, Yu
Izawa, Naoki
Horie, Yoshiki
Xiang, Silong
Xu, Siying
Qin, Lan
Gong, John
Liu, David
Pokaż więcej
Źródło:
Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 40(5):1021-1031
Czasopismo naukowe
Tytuł:
Practical consideration for successful sequential tumor biopsies in first-in-human trials
Autorzy:
Koyama, Takafumi
Shimizu, Toshio
Sato, Jun
Katsuya, Yuki
Iwasa, SatoruAff1, Aff2
Kondo, ShunsukeAff1, Aff3
Yoshida, TatsuyaAff1, Aff4
Sudo, KazukiAff1, Aff5
Nishino, Makoto
Takiguchi, Yuichi
Yonemori, KanAff1, Aff5
Yamamoto, NoboruAff1, Aff4, IDs10637022012364_cor12
Pokaż więcej
Źródło:
Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 40(4):841-849
Czasopismo naukowe
Tytuł:
Introducing AI to the molecular tumor board: one direction toward the establishment of precision medicine using large-scale cancer clinical and biological information
Autorzy:
Hamamoto, RyujiAff1, Aff2, IDs40164022003337_cor1
Koyama, Takafumi
Kouno, NobujiAff1, Aff4
Yasuda, TomohiroAff1, Aff5
Yui, ShuntaroAff1, Aff5
Sudo, KazukiAff3, Aff6
Hirata, Makoto
Sunami, Kuniko
Kubo, Takashi
Takasawa, KenAff1, Aff2
Takahashi, SatoshiAff1, Aff2
Machino, HidenoriAff1, Aff2
Kobayashi, KazumaAff1, Aff2
Asada, KenAff1, Aff2
Komatsu, MasaakiAff1, Aff2
Kaneko, SyuzoAff1, Aff2
Yatabe, YasushiAff9, Aff10
Yamamoto, Noboru
Pokaż więcej
Źródło:
Experimental Hematology & Oncology. 11(1)
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies